ClinicalTrials.gov
public full text
Public Domain
Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19
This Phase 2b study will evaluate the pharmacokinetics (PK), pharmacodynamics (PD) and safety of sotrovimab in pediatric participants from birth to less than (\<)18 years old with mild-to-moderate Coronavirus Disease-2019 (COVID-19) at high risk of disease progression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design#780556
- Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD#1007197
- Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19#871590
- Long-term Follow-up Study of COVID-19#826991
- Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment#1163155
Record · ID 902093
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive